
Advances in lupus research in Latin América
Author(s) -
Gloabl Rheumatology By Panlar
Publication year - 2021
Publication title -
global rheumatology
Language(s) - English
Resource type - Journals
ISSN - 2709-5533
DOI - 10.46856/grp.233.et084
Subject(s) - latin americans , public health , systemic lupus erythematosus , family medicine , medicine , covid-19 , disease , pediatrics , political science , nursing , infectious disease (medical specialty) , law
"In this video blog, we will talk with José Gómez-Puerta, head of the Rheumatology Service at the Hospital Clinic de Barcelona, associate professor at the University of Barcelona and master's degree in Public Health from the Harvard School of Public Health, about the research carried out in Latin America on lupus by the GLADEL group and the key messages for patients and families, as well as existing relationships with covid-19." "Lupus is a treatable, controllable disease, where every day better treatment and better markers are being developed for its diagnosis and control. Consult a specialist for any warning sign or symptom out of the ordinary,"" he says."